Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 281articles · 30d
- 5+ hour agolatest article
- Aug 17, 2026earliest in window
- 91%with images
- 289avg words
- Economy, Business & Finance 160
- Health & Wellness 129
- Medical 128
- Business & Industrial 117
- Finance & Business 105
- Health 59
- Science & Technology 48
- Science & Nature 33
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Aptar Pharma Expands Preservative Free Technology Production in Latin America
9+ hour, 2+ min ago (318+ words) BioSpace Aptar Pharma Expands Preservative Free Technology Production in Latin America Transfer of Aptar Pharma’s Advanced Preservative Free pump technology to Berazategui, Argentina, strengthens local manufacturing capabilities and supports the company’s local-for-local approach in the region. Located south of Buenos…...
Novartis’ board faces investor scrutiny after M&A misfires and R&D flops
3+ day, 4+ hour ago (469+ words) Novartis went into September looking forward to three readouts that analysts had identified as central to its mid- to long-term growth prospects. Days later, the Swiss drugmaker was reeling from the failures of two of the pivotal trials, offsetting success in…...
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
3+ day, 8+ hour ago (313+ words) NEW YORK and ATHENS, Greece, Sept. 10, 2026 /PRNewswire/ -- Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael Kalos, PhD, as Venture Partner. Dr. Kalos brings decades of biopharmaceutical executive leadership, drug discovery,…...
NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE
3+ day, 8+ hour ago (319+ words) SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference, to be…...
Takeda’s long-term R&D head announces exit after major pipeline reorganization
3+ day, 17+ hour ago (499+ words) iStock, Agdekon Media Visuals Takeda’s R&D chief Andy Plump will say good-bye to the drugmaker, with a retirement slated for next summer. “Andy has made the personal decision to retire in June 2027 after more than 10 years leading Takeda’s global…...
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
4+ day, 37+ min ago (133+ words) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first…...
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
3+ day, 19+ hour ago (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
3+ day, 20+ hour ago (194+ words) BioSpace Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief…...
Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
4+ day, 1+ hour ago (274+ words) Biohaven stock fell more than 13% in premarket trading Thursday as the FDA slapped a partial clinical hold on its Kv7 potassium channel agonist in focal epilepsy. This latest development comes days after SK Biopharmaceuticals snagged a worldwide license to the Kv7 platform,…...